macrocyclic peptide complement inhibitor
Is Zilucoplan legal?
Answer
Zilucoplan is authorised or registered in 7 of the 10 registers read: United States, European Union, United Kingdom, Canada, Australia, Switzerland, Turkey.
Each row is what that country's own register said on the date shown. Not legal advice.
| Country | Status | Products on the register | Register | Read |
|---|---|---|---|---|
| United States | FDA-approved | Zilbrysq | Regulator FDA | 2026-10-03 |
| European Union | Authorised | Zilbrysq | Regulator EMA | 2026-10-03 |
| United Kingdom | Authorised | Zilbrysq | Regulator MHRA | 2026-10-03 |
| Canada | Authorised | Zilbrysq | Regulator Health Canada | 2026-10-03 |
| Australia | Registered | Zilbrysq | Regulator TGA | 2026-10-03 |
| Switzerland | Authorised | Zilbrysq | Regulator Swissmedic | 2026-10-03 |
| Brazil | Not on the register | - | Regulator ANVISA | 2026-09-03 |
| Serbia | Not on the register | - | Regulator ALIMS | 2026-09-03 |
| Singapore | Not on the register | - | Regulator HSA | 2026-09-03 |
| Turkey | Ruhsatli | Zilukoplan Sodyum | Regulator TITCK | 2026-09-03 |
A country not listed has no register read yet; see the world map. EU decisions also apply in Iceland, Liechtenstein and Norway.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.